Skip to main content
Stuart Goldberg, MD, Oncology, Hackensack, NJ

StuartLeighGoldbergMD

Oncology Hackensack, NJ

John Theurer Cancer Center at Hackensack University Medical Center

Dr. Goldberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Goldberg's full profile

Already have an account?

Summary

  • Stuart Goldberg MD currently serves as the Chief, Division of Outcomes and Value Research at the John Theurer Cancer Center, and previously was a Chief Division of Leukemia and Member of the Center's Bone Marrow Transplant Program. He is involved in the clinical care of patients with Acute and Chronic Leukemia, MDS and other bone marrow failure diseases. The program is an MDS Foundation Center of Excellence (and serves on the MDS Foundations Development Board), and Dr Goldberg is a medical advisor to the NJ Leukemia Society. He is the principal investigator of over 30 active trials and currently an international co-chair on the SIMPLICTY CML trial. Dr Goldberg lectures extensively on various topics and has discussed the role of chelation therapy in MDS on 5 different continents. Dr Goldberg also served as the Chief Medical Officer of COTA Inc, a medical data and analytics company founded at the John Theurer Cancer Center. COTA seeks to find value in healthcare.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1991 - 1992
  • George Washington University
    George Washington UniversityFellowship, Hematology and Medical Oncology, 1989 - 1991
  • George Washington University
    George Washington UniversityResidency, Internal Medicine, 1986 - 1989
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 1986

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1998 - 2025
  • DC State Medical License
    DC State Medical License 2019 - 2020
  • PA State Medical License
    PA State Medical License 1989 - 2010
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • David King Clinical Scientist Award Association of Community Cancer Centers, 2016
  • Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2015
  • Inside Jersey Magazine Top Doctors Castle Connolly, 2012-2015
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase 2b Study of Two Dosing Regimens of Quizartinib Monotherapy in FLT3-ITD Mutated, Relapsed or Refractory AML  
    Alexander E Perl, Mark J Levis, Stuart L Goldberg, Martin S Tallman, Hagop M Kantarjian, Gary J Schiller, Blood

Abstracts/Posters

  • Blinatumomab in Combination with Tyrosine Kinase Inhibitors Safely and Effectively Induces Rapid, Deep, and Durable Molecular Responses in Relapsed and Refractory Phil...
    Stuart L. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Sustained Hematopoietic Recovery after Salvage Autologous Stem Cell Transplants after Long Term Storage of Cryopreserved Hematopoietic Progenitor Stem Cells (HPSC)
    Stuart L. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Evomela¬ Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation
    Stuart L. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Cardiovascular (CV)-Related Hospitalizations and Associated Costs Among US Patients in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloi... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Dosing Patterns of Dasatinib Use in Simplicity, an Observational Study in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients (pts) in Routine Clinical Practice 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • New Model Can Help Clinicians to Predict 40-Day Mortality Risk in Hospitalized COVID-19 Patients
    New Model Can Help Clinicians to Predict 40-Day Mortality Risk in Hospitalized COVID-19 PatientsAugust 2nd, 2021
  • Hope Dims for Hydroxychloroquine Even as Medical Study Detailing the Drug’s Failure Is Retracted
    Hope Dims for Hydroxychloroquine Even as Medical Study Detailing the Drug’s Failure Is RetractedJune 5th, 2020
  • On the Front Lines During the First Wave of COVID-19 Pandemic: Hackensack Meridian Health Publishing
    On the Front Lines During the First Wave of COVID-19 Pandemic: Hackensack Meridian Health PublishingJune 5th, 2020
  • Join now to see all

Committees

  • Development Board, Myelodysplastic Syndromes Foundation 2016 - Present
  • Medical Advisory Board, Leukemia Society (NJ Chapter) 2002 - Present

Professional Memberships